Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations
News | Radiation Therapy
New Study Reveals Targeted Therapy Working in Early Breast Cancer

April 22, 2021 — Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate ...

Time April 22, 2021
arrow
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence
Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

April 8, 2021 — Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) ...

Time April 08, 2021
arrow
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.
News | Artificial Intelligence
Vysioneer Receives FDA Clearance on First-Ever Tumor Auto-Contouring Solution for Radiation Therapy

April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S. Food ...

Time April 07, 2021
arrow
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy
ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses

March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced ...

Time March 31, 2021
arrow
Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) – a type of radioembolization comprised of millions of microscopic glass beads containing radioactive yttrium (Y-90) – during a late-breaking clinical trial presentation at the annual scientific meeting for the Society of Interventional Radiology (SIR).
News | Interventional Radiology
Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

March 25, 2021 — Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 ...

Time March 25, 2021
arrow
Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform.
News | Radiation Therapy
Northern Sydney Cancer Centre Partners with Sun Nuclear as Newest SunCHECK Platform Reference Site

March 25, 2021 — Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a ...

Time March 25, 2021
arrow
A new study led by Ivan Martinez—associate professor in the WVU School of Medicine and Cancer Institute—found a link between a family of RNAs, the Y chromosome, and radiation sensitivity in male lung-cancer patients
News | Radiation Therapy
Loss of Y chromosome, RNA Tied to Radiation Resistance in Male Lung-cancer Patients

March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19 ...

Time March 23, 2021
arrow
Cancer tissue being bombarded by targeted alpha particles. The generator developed by Los Alamos National Laboratory holds uranium-230, which decays to thorium-226. Further decay produces short-lived daughter isotopes, emitting four more alpha particles resulting in a very high combined radiation dose to destroy cancer cells.
News | Radiation Therapy
New Los Alamos Generator System Delivers Large Radiation Doses Directly to Cancer Cells

March 23, 2021 — Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos ...

Time March 23, 2021
arrow
Radiofrequency ablation for the palliative treatment of osseous metastases reduces pain and improves quality of life
News | Interventional Radiology
Minimally Invasive Treatment Provides Fast Pain Relief for Cancer Patients

March 19, 2021 — A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and ...

Time March 19, 2021
arrow
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.
News | Radiation Therapy
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Time March 18, 2021
arrow
Stefan Vilsmeier Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research
News | Treatment Planning
Brainlab Acquires Mint Medical

March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image ...

Time March 10, 2021
arrow
Methodology for evaluation of tumor cell density (TCD) and allocation of radiotherapy response categories. (A) Virtual graticule of approximately 300 points applied to tumor area on a digital H&E section. (B) Demonstration of TCD point scoring. (C) Box and whisker plot to show the relationship between ΔTCD and American Joint Committee on Cancer (AJCC) Tumour Regression Grade System (TRG). (D, E) Allocation of three radiotherapy response groups according to change in TCD (ΔTCD) for short-course radiotherapy
News | Radiation Oncology
Targeted Immunotherapy Could Boost Radiotherapy Response

March 9, 2021 — Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with ...

Time March 09, 2021
arrow
Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.
Feature | Treatment Planning | By Melinda Taschetta-Millane
Using PET to Enhance Prostate Treatment Planning

The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and ...

Time March 05, 2021
arrow
“Distinction in Stereotactic Radiotherapy” offers comprehensive accreditation program for SRS/SBRT clinical practice and physics quality assurance
News | Stereotactic Body Radiation Therapy (SBRT)
The Radiosurgery Society Announces Launch of Joint Accreditation Program with The American College of Radiation Oncology

February 26, 2021 — The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and ...

Time February 26, 2021
arrow
Immunotherapy-based precision medicine clinical trials being developed
News | Prostate Cancer
Why Black Men's Prostate Cancer May be More Responsive to Immunotherapy

February 16, 2021 — Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from ...

Time February 16, 2021
arrow
ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.
News | Stereotactic Body Radiation Therapy (SBRT)
ZAP Surgical Builds Market for its Novel ZAP-X Gyroscopic Radiosurgery Platform

February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ...

Time February 12, 2021
arrow
News | Prostate Cancer
Ultrasound Technique Treats Prostate Cancer with Minimal Side Effects

February 5, 2021 — A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance ...

Time February 05, 2021
arrow
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.
News | Radiation Dose Management
New Imaging Intellectual Property for Lower Radiation Dose

February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND ...

Time February 05, 2021
arrow
 GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — announced the addition of a game-changing adaptive therapy, the Ethos.
News | Radiation Therapy
GenesisCare Brings Florida Cancer Patients First-of-its-Kind Ethos Adaptive Intelligence Technology

February 4, 2021 — GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the ...

Time February 04, 2021
arrow
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab.
News | Radiation Therapy
Ludwig Cancer Research Study Reveals How Certain Gut Bacteria Compromise Radiotherapy

January 28, 2021 — A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of ...

Time January 28, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now